Smart Money Circle

Description: Guest: Peter Krull, Partner and Director of Sustainable Investing at Earth Equity Advisors around $200M Website: EarthEquityAdvisors.com ​Here’s more information on Peter's Green Sage Sustainability Portfolio: https://www.earthequityadvisors.com/green-sage/ Here is the link to the book Peter Mentioned: https://www.amazon.com/Essentialism-Disciplined-Pursuit-Greg-McKeown/dp/0804137404 Bio: Peter Krull, CSRIC, is a Partner and the Director of Sustainable Investing at Earth Equity Advisors, a Prime Capital Financial Company. He is also the 2024 Investment News ESG/Responsible Investing Advisor of the Year, 1 and a well-known thought leader in the sustainable investment industry, advocating for fossil-fuel-free and sustainable, responsible, and impact (SRI) investing. Practicing sustainable investing for over 20 years, Peter believes in the power of positive, solutions-based investing. At Earth Equity, Peter focuses on creating and managing the firm’s SRI investment portfolios, educating investors and advisors alike on the dangers of greenwashing, and writing thought leadership pieces. In 2021, Peter won the ThinkAdvisor Luminaries Award for Thought Leadership and Education 2 as well as the Sustainable Champion Award from the North Carolina Business Council in 2022. 3 He was ranked in the AdvisorHub listing of fastest-growing advisors in America for 2022. 4 Peter is a contributor to Forbes and Kiplinger and has been quoted in The New York Times, Barron’s, Bloomberg, Money Magazine, Investor’s Business Daily, MarketWatch, and many others. In addition, he has been regularly featured in numerous podcasts, magazines, and online articles. He hosts the video podcast, Dollars; Change: The Experts Guide to Sustainable and Responsible Investing and his book The Sustainable Investor: A Guide to Responsible Investing for Financial Advisors will be released by Wiley in 2025. A native of Western New York, Peter lives in Asheville, NC, with his wife, Dr. Melissa Booth, a scientist, science communicator, and novelist, and their very spoiled cat, Cleo. They drive electric vehicles and live in a solar and battery-powered house. 1 Awarded June 2024 for the 2023-2024 year period by InvestmentNews. No compensation was provided. 2 Awarded November 2021 for the year 2021 by ThinkAdvisor. No compensation was provided. 3 Awarded January 2023 by the North Carolina Business Council for the year 2022. No compensation was provided. 4 Awarded November 2022 by AdvisorHub for the year 2022. No compensation was provided. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Timeless Lessons From A Money Manager That Helps Tech Employees Invest Their Money Guest name: Eric Franklin Title: Managing Principal, Co-Founder Website: www.prosperowealth.com AUM: $60M Bio: Eric is the Managing Principal and Owner of Prospero Wealth, a financial planning and wealth management firm dedicated to inspiring tech professionals to live larger and more impactful lives. Prospero Wealth is the only advisory practice to focus on this large and affluent population by providing a highly curated set of data-driven products and services, and by training multi- decade tech veterans to act as lead advisors. Despite relatively high pay and benefits, a 2020 Gartner survey found that two out of three tech workers were open to or already seeking jobs in other industries. Tech professionals are highly educated and skeptical of financial salespeople. Prospero Wealth has found them to be more comfortable working with advisors that have a similar career background and who have already made similar career switches they are looking to make for themselves (“second-act” careers with larger personal satisfaction and control). Prior to starting Prospero Wealth, Eric worked 23 years in technology, most notably at Amazon for over 18 years (over three separate terms starting in 1998) where he was an early product owner for Customer Reviews and Wish Lists, managed teams of product managers delivering category expansion for Amazon, and designed a large-scale technology platform for Customer Service triggering automated actions in response to large scale anomaly detection. In between those three stints at Amazon, Eric also worked in a number of startups as the head of product. Eric holds a B.A. degree in literature from the University of California, Santa Cruz, and lives in Seattle with his wife and two children. He loves taking the family skiing (even though he is a lifelong snowboarder), spinning vinyl in his home office, and is an avid reader. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Risk Can Be An Opportunity. $TRX Gold CEO Explains What’s Next & How Gold Is A Database Business Guest: Stephen Mullowney, Chief Executive Officer, Director, TRX Gold Corporation Website: https://trxgold.com/ Bio: Stephen Mullowney was appointed CEO of TRX Gold in December 2020. He is a former Partner and Managing Director at PricewaterhouseCoopers LLP (PwC), where he led PwC Canada’s Deals Mining Group for more than ten years. Mr. Mullowney has an extensive mining background, working with miners, Governments, and institutional investors across the world and supporting them in making key strategic business, financing, and policy decisions. Mr. Mullowney is a CA, CPA, CFA and holds a BBA from Acadia University. Ticker: NYSE/AMERICAN and TSE – $TRX --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Asset Protection Attorney Blake Harris Shares How The Top 1% Protect Their Assets With Offshore Trusts Website: https://blakeharrislaw.com/ Bio: Blake Harris is the founding principal at Blake Harris Law, where he assists clients throughout the world with Offshore Asset Protection. Having traveled to over 40 countries, Blake has built an extensive global network by meeting with trust companies, protectors, and bankers worldwide. An accomplished author and international speaker, Blake has educated countless professionals through his continuing legal education lectures on asset protection and offshore planning. He has been quoted in numerous national publications, including Forbes, The Epoch Times, ABC, NBC, CBS, Fox News, and MarketWatch. Beyond these accolades, Blake boasts a significant social media presence with hundreds of thousands of followers, further solidifying his influence in the field. With a seasoned background in wealth management, Blake Harris previously worked with one of America’s premier wealth management firms, advising high and ultra-high-net-worth clients on strategies to safeguard their assets. His passion for helping families cultivate and preserve their legacy inspired him to establish Blake Harris Law, a firm deeply committed to providing tailored solutions and peace of mind for its clients. Blake’s commitment to the field doesn’t stop at his firm. He has consistently been recognized as a “Rising Star” by Super Lawyers Magazine for the past 5 years and is an AV®️ Preeminent™️ Attorney. A proud alumnus of the University of Florida, Blake obtained a degree in finance in 2007 and went on to earn his Juris Doctorate from the University of Florida Levin College of Law in 2010, a top-tier law school. Blake is an active member of the American Bar Association, International Bar Association, the Florida Bar since 2010 (Florida Bar number: 86486), and the Colorado Bar since 2013 (Colorado Bar number: 45942). Blake resides in Miami Beach, in his limited free time, he enjoys traveling internationally, swimming in the ocean, and Muay Thai training. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This Sustainable Food CEO Wants To Help You Eat Better. Meet John Keeler Founder & CEO Of Blue Star Foods, $BSFC Company: Blue Star Foods Ticker: $BSFC Website: https://bluestarfoods.com/ John’s Bio: John Keeler Founder & CEO Founded BSFC in 1995; successfully built sales over the past 26 years to $20+ million annually and is recognized as a leader and innovator in the measurable ESG enterprise model within the seafood industry. BS in Economics from Rutgers University; attended Harvard Business School Executive Programs focused on supply chain management, negotiations and marketing. Named Best CEO in Sustainable Seafood Industry by European CEO Magazine. 2017 Speaker at “The Economist World Ocean Summit”. Company Profile Blue Star Foods Corp., an international seafood company, processes, imports, packages, and sells refrigerated seafood products. It offers pasteurized crab meat, and other seafood products, under the Blue Star, Pacifika, Oceanica, Crab & Go Premium Seafood, Lubkin, First Choice, Good Stuff, and Coastal Pride Fresh brands. The company sells its products to food service distributors, wholesalers, retail establishments, and seafood distributors in the United States, Canada, and Europe. Blue Star Foods Corp. was formerly known as John Keeler & Co. Inc. Blue Star Foods Corp. was founded in 1995 and is headquartered in Miami, Florida. Blue Star Food Corp. (Nasdaq: BSFC) seeks to enhance shareholder value not only through exceptional business performance and practices, but also through responsible and effective communication with its shareholders. The latest company information relevant to the individual and institutional investor includes stock price and history, upcoming events and presentations and financial documents. Blue Star Foods is traded on the Nasdaq under the ticker symbol $BSFC. Learn more here: https://bluestarfoods.com/ --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM Guest: Geert Kersten CEO of CEL SCI Corp $CVM Ticker: $CVM Website: https://cel-sci.com/ Geert Kersten Biography Geert Kersten has served in his current leadership role as Chief Executive Officer at CEL-SCI Corporation (NYSE American: CVM) since 1995 and has been with CEL-SCI since 1987. He has been involved in the pioneering field of cancer immunotherapy for over three decades and has successfully steered CEL-SCI through many challenging cycles in the biotechnology industry. Mr. Kersten also provides CEL-SCI with significant expertise in the fields of finance and law and has a unique vision of how CEL-SCI's Multikine product could potentially change the way cancer is treated. Prior to joining CEL-SCI, Mr. Kersten worked at the law firm of Finley & Kumble and worked at Source Capital. Mr. Kersten received his Undergraduate Degree in Accounting and an M.B.A. from George Washington University, and a law degree (J.D.) from American University in Washington, DC. Investors Can Learn More: https://cel-sci.com/new-investor-information/ --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Guest: Dr. Shankar Musunuri - Ocugen, Chairman, Chief Executive Officer, and Co-founder Website: www.ocugen.com Ticker: OCGN Bio: Dr. Shankar Musunuri is Chairman, CEO and Co-Founder of Ocugen. The company (NASDAQ: OCGN) is a publicly traded biotechnology company focused on discovery, development, commercialization of gene therapies, cell therapies, biologicals, and vaccines, based in Malvern, Pennsylvania. Dr. Musunuri transformed Ocugen from a start-up into a cutting-edge science-based biotech powerhouse with three distinct first-in-class platform technologies focused on ophthalmology with a first-in-class modifier gene therapy platform targeting rare as well as large blindness diseases, orthopedics with a regenerative cell therapy platform, and infectious diseases with an inhalation vaccine platform targeting Covid-19, flu, and a combination vaccine for both COVID-19 and flu. Ocugen anticipates launching products from these game-changing platform technologies within the next few years. The company’s mission is to develop cutting-edge innovations for people with serious diseases and conditions with a commitment to ensuring global market access. Dr. Musunuri is a seasoned biotech veteran with 30+ years’ experience advancing and commercializing a diverse portfolio of products. Prior to co-founding Ocugen in 2013, he held leadership roles at numerous companies ranging from large multinational biotechnology companies such as Wyeth and Pfizer, to novel start-up biotech companies. During his 15 years at Pfizer, he gained extensive product launch and life-cycle management experience including leading the Global Operations Team for Prevnar 13, the world’s best-selling vaccine. Dr. Musunuri then founded Nuron Biotech, Inc., which grew into a commercial company in less than three years. Dr. Musunuri obtained his PhD in Pharmaceutical Sciences from the University of Connecticut—where he also received a Distinguished Alumnus Award. He also received an MBA from Duke University, where today he serves on the University’s Innovation & Entrepreneurship Board of Advisors. Dr. Musunuri serves as both CEO and Chairman of the board of Ocugen. He has received numerous leadership awards including Most Admired CEO Award by Philadelphia Business Journal, the 2023 Healthcare Power 100 (ranked 22nd) in PA and the 2023 AAPI Power 100 (ranked 11th) in PA. He is also a Board Member of the Musunuri Family Foundation, a non-profit that provides college scholarships for high school students. Dr. Musunuri has a passion for addressing diseases and conditions which lack effective treatments. This commitment is reflected in Ocugen’s mission of relentlessly pursuing courageous innovation on behalf of patients with unmet medical needs. About Ocugen, Inc. Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients’ lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. Discover more at www.ocugen.com --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Conor McGregor Invested in this MMA Stock. Meet Nick Langton Founder & CEO Alta Global Ticker $MMA Conor McGregor Invested in this MMA Stock. Meet Nick Langton Founder & CEO Alta Global Ticker $MMA Guest: Nick Langton Founder & CEO Alta Global Ticker $MMA Website: trainalta.com ABOUT ALTA GLOBAL GROUP LIMITED Alta Global Group Limited is a technology company that is seeking to increase consumer participation in martial arts and combat sports whilst building upon existing community offerings within the sector. Alta currently has three business units designed to provide services to and monetize all key stakeholders in the sector, namely fans, participants, coaches, gym owners and athletes. · TrainAlta (www.trainalta.com) partners with gyms and coaches to deliver a range of consumer products that drive participation in martial arts for fans and beginners. · Hype (www.hype.co) is a mobile marketing platform designed to help gym owners, coaches and athlete partners grow revenue from their followers and audiences in today's age of social media. · MixedMartialArts.com (www.mixedmartialarts.com) is a leading platform for the MMA community, providing access to MMA news and media, fighter data, fight schedules and access to the legendary Underground forum. For further information about Alta Global Group Limited (NYSE American: MMA), please visit www.altaglobalgroup.com Follow us on social media via Facebook, X, Instagram, or LinkedIn @trainalta. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Guest: John Cash CEO and Chairman of the Board for Ur-Energy Inc. Ticker: URG Ticker: URG Website: https://www.ur-energy.com/ Bio: Mr. Cash was appointed Chairman of the Board of Directors and CEO of Ur-Energy Inc. in 2022. Mr. Cash joined Ur-Energy in 2007 and was appointed as Vice President Regulatory Affairs in 2011. He led the permitting and licensure of both the Lost Creek and Shirley Basin uranium mines, while managing the environmental, health and safety and geology departments and contributing to the development and growth of the Company. During his tenure with Ur-Energy, Mr. Cash gained a well-deserved reputation for developing impactful solutions for industry related to water management, EPA aquifer exemptions, technical design, and environmental matters. Mr. Cash has nearly 30 years of diverse experience in the uranium industry, from which he has acquired broad-reaching expertise in exploration, radiation safety, regulatory and legislative affairs, and uranium recovery operations, as well as extensive management experience. He is a respected industry leader and has served as a past president of the Uranium Producers of America. Mr. Cash is a Fellow of the inaugural World Nuclear Summer Institute and received B.Sc. and M.Sc. degrees in Geology and Geophysics from the University of Missouri-Rolla. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Forget Ozempic & Wegovy. The Biggest Opportunity In Weight Loss Today. Lose Weight, Not Muscle $VERU Guest: * CEO: Dr. Mitchell Steiner * Title: Founder, Chairman, CEO, and President * Website: www.verupharma.com * Ticker: NASDAQ: Veru * Bio: Mitchell S. Steiner, M.D., F.A.C.S. has served as President and Chief Executive Officer of Veru and as a director of the Company since October 2016. Dr. Steiner was the co-founder of Aspen Park and served as Aspen Park's Chief Executive Officer, President and Vice Chairman of the Board from July 2014 to October 2016. From 2014 to 2016, Dr. Steiner was a consultant and then the President, Urology and member of senior management of OPKO Health, Inc. (NYSE:OPK) and had responsibilities for the launch, marketing, sales and reimbursement of 4Kscore prostate cancer test to urologists and primary care physicians. Dr. Steiner was also the co-founder of GTx, Inc., a men's health and oncology public company, where he served as Chief Executive Officer and Vice Chairman of Board of Directors from 1997 to 2014. Dr. Steiner is a Board Certified Urologist and a Fellow of the American College of Surgeons and has held numerous academic appointments, including Assistant Professor of Urology, Cell Biology, and Pathology at Vanderbilt School of Medicine from 1993 to 1995 and Chairman and Professor of Urology, Director of Urologic Oncology and Research and the Chair of Excellence in Urologic Oncology at the University of Tennessee from 1995 to 2004. Dr. Steiner holds a B.A. in Molecular Biology and Chemistry from Vanderbilt University and an M.D. from the University of Tennessee. He performed his surgical and urologic training at The Johns Hopkins Hospital and postdoctoral research fellow in cell biology at Vanderbilt School of Medicine. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Dallas Cowboys Owner Jerry Jones Invested In GameSquare. The CEO Explains The Future Of Sports $GAME Guest: Justin Kenna CEO of GameSquare Holdings, Inc., (NASDAQ: GAME) Company: GameSquare Holdings Inc. ($GAME) Website: https://www.gamesquare.com/ CEO Bio: Justin Kenna is the CEO of GameSquare Holdings, Inc., (NASDAQ: GAME) (TSXV: GAME) an international esports and gaming company revolutionizing the way brands and game publishers connect with hard-to-reach Millennial and Gen Z audiences. He drives strategic direction, integrating global brands within gaming communities through GameSquare's media agencies, data and analytics solutions, SaaS platforms, esports organizations, and content studio. A seasoned executive with extensive experience in gaming, digital media, and finance, Kenna was recognized in the Leaders Under 40 Sports Business Awards Class of 2023 and on the 2023 Dallas 500 list of the most powerful and influential CEOs in North Texas. As former CFO of FaZe Clan, he helped grow one of the world's most globally recognized gaming brands, which he then acquired in 2023 at GameSquare. He has also held finance roles at Madison+Vine, Goldman Sachs, Ernst & Young, and Deloitte and belongs to the Institute of Chartered Accountants. Under his leadership, GameSquare has partnered with over 150 global brands, including Lenovo, Mastercard and Kraft-Heinz, and established collaborations with major sports leagues like the NFL. His efforts have fostered inclusivity in gaming through campaigns with blue chip brands. Kenna's strategic leadership has attracted prominent investors and board members, including Dallas Cowboys owner Jerry Jones and the Goff Family. Kenna lives in Dallas with his wife and daughter. Company Bio: Building the future of sports. GameSquare's (NASDAQ: GAME) mission is to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Our next generation media, entertainment, and technology capabilities drive compelling outcomes for creators and maximize our brand partners' return on investment. Through our purpose-built platform, we provide award winning marketing and creative services, offer leading data and analytics solutions, and amplify awareness through FaZe Clan, one of the most prominent and influential gaming organizations in the world. With one of the largest gaming media networks in North America, as verified by Comscore, we are reshaping the landscape of digital media and immersive entertainment. GameSquare's largest investors are Dallas Cowboys owner Jerry Jones and the Goff family. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

How This CEO Creates & Captures Value Sam Rubin President and CEO LightPath Technologies - $LPTH Ticker: $LPTH Website: https://www.lightpath.com/ Guest: Sam Rubin, President & Chief Executive Officer LightPath Technologies (NASDAQ: LPTH) Bio: In Mr. Rubin’s prior senior executive role at Thorlabs, he was responsible for Thorlabs’ Imaging Systems Division, a standalone organization with its own sales and marketing, as well as global responsibility for all of Thorlabs’ Life Science activities. Among the positions he held at Thorlabs, Mr. Rubin founded and grew Thorlabs’s fast-growing operation in China, and spearheaded Thorlabs’ entry and significant growth in the Life Sciences market. As a member of the senior executive team, Mr. Rubin leads new strategic initiatives for Thorlabs, including new product lines, acquisitions, and growth into new markets. Prior to joining Thorlabs, Mr. Rubin co-founded XLight Photonics, an optical communication startup, which was later sold to a telecommunications private equity firm. Mr. Rubin holds a Bachelor of Science degree in Electronic Engineering from Ben Gurion University, a Master of Business Administration degree from New York University, Stern School of Business, and is a graduate of the Executive Education, Program for Leadership Development at Harvard Business School. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-MBIO This CEO is Using LSD To Fight Depression, PMS, and Other Mental Health Conditions – Justin Hanka CEO -Co-Founder Of Mind Bio Therapeutics -CSE-MBIO Justin Hanka | Co-founder | Chief Executive Director MindBio Therapeutics Ltd Ticker: $MBIO – Canada. Frankfurt Börse - FRA: WF6 Website: https://www.mindbiotherapeutics.com/ Bio: Justin works in investment banking and financing of mergers and acquisitions and particularly he specializes in capital markets transactions and working with technology in the life and health sciences sector. He is Non-Executive Director of EonX (CSE:EONX), a financial technology company, Non-Executive Chairman of Blackhawk Growth Corp (CSE:BLR), an investment issuer and Non-Executive Director and Chairman of SPARC AI (CSE:SPAI), an engineering company commercializing covert geospatial location and tracking technology for drones. Justin is Co-Founder and CEO of Hardenbrook Group, a merchant and investment bank and Co-founder and CEO of MindBio Therapeutics (CSE:MBIO), a clinical stage pharma developing psychedelic microdosing formulations to treat depression and is currently dosing in multiple Phase 2B clinical trials. Justin is also Co-founder of Life AI Corp, a life sciences technology company developing AI solutions for longevity and enhancing health and wellness at scale. Justin’s expertise and interests span the pharmaceutical and life sciences sector, fin-techs, technology that utilizes AI and machine learning methods, banking and insurance, health and wellness, biohacking, anti-ageing and ecommerce. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Guest: Paul Warley CEO and President Ascent Solar Technologies Website: https://ascentsolar.com Ticker Symbol: ASTI Bio: Chief Executive Officer Prior to Ascent, Warley was president of Warley & Company LLC, a strategic advisory firm from 2015 to 2022 – providing executive management services, capital advisory, and M&A to middle-market companies in the service, construction, technology, oil & gas, clean energy, food, retail and green-building sectors. While at Warley & Company from 2018 to 2019, he was engaged as chief executive officer and CFO of 360Imaging, a provider of products and services for implant surgery and digital dentistry. From 2011 to 2015, Warley served clients in the alternative energy industry as a managing director and chief compliance officer with Deloitte Corporate Finance. From 1997 to 2011, Warley was managing director and region manager for GE Capital. From 1984 to 1997, Warley served as senior vice president with Bank of America and Bankers Trust. Company Bio: Backed by 20+ years of R&D, 17 years of manufacturing experience, numerous awards, and a comprehensive IP and patent portfolio, Ascent Solar Technologies, Inc. (ASTI) is a leading provider of innovative, high-performance, flexible thin-film solar panels for use in scenarios where traditional rigid solar panels don’t work. Ascent’s photovoltaic (PV) modules have been deployed on space missions, multiple airborne vehicles, agrivoltaic installations, in industrial and commercial construction, and in consumer goods, revolutionizing the use cases and environments for solar power. Ascent Solar’s Headquarters & Perovskite Manufacturing Center of Excellence are located in Thornton, Colorado. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This CEO Is Using A.I. & Psychedelics To Improve Mental Health Guest: Kathryn Walker is the Founder CEO of Revitalist Lifestyle and Wellness -CSE CALM- RVLWF Ticker: (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) Website: https://revitalistclinic.com/ Bio: About Kathryn Walker Kathryn Walker is the CEO of Revitalist Lifestyle and Wellness (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) which serves as a leading mental health and wellness company led by a comprehensive team of specialty providers. Kathryn worked at a Level 1 Trauma Center in Tennessee for 9 years before attending anesthesia school at the University of North Carolina-Charlotte. She practiced anesthesia of all specialties for 8 years before opening the first Revitalist location in Knoxville, TN in 2018. Today Kathryn operates as a leading advocate for psychedelic medicine as she continues to advance her comprehensive skill set recently graduating with her second Master's degree in Psychiatric Nursing as a Psychiatric Mental Health Nurse Practitioner. Recognizing the need for community access, Kathryn founded the national mental health 501c3 nonprofit, Community Change Foundation (CommunityChangeFoundation.org). This nonprofit foundation focuses on providing financial assistance to veterans, frontline workers, and the financially disadvantaged seeking help with psychedelic therapies. Kathryn incorporated the Community Change Foundation in 2019. Recognizing the need for education and training advancements, Kathryn founded the American Association of Psychedelics (AAPsychedelics.org). This education non-profit 501c3 aims to continually bring high quality education and training to all disciplines of providers. Kathryn incorporated the American Association of Psychedelics in 2021. Kathryn is the Academic Detailer for the MetroDrug Coalition, she sits on the board for American Association of Psychedelics, Mental Health Association of East Tennessee, Herzig University, and Women in Psychedelics. About Company About Revitalist Lifestyle and Wellness Ltd. Revitalist (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is a mental health and wellness company focused on comprehensive care in the ketamine wellness space offering innovative, evidenced-based services. The Company, through its subsidiary Revitalist, operates physical locations and virtual offices across 35 states. Founded and led by Kathryn Walker, an advanced provider in the psychedelic space, Revitalist is at the forefront of this emerging field. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Guest: Dr. Lynn Kirkpatrick Chief Executive Officer, Ensysce Biosciences Inc. Ticker: $ENSC (NASDAQ) Website: https://ensysce.com/ Bio: Dr. Lynn Kirkpatrick Chief Executive Officer, Ensysce Biosciences Inc. Dr. Kirkpatrick has focused her entire career on drug discovery and development. Former Professor of Chemistry and Biochemistry in Canada, she has been active in both the novel drug discovery as well as clinical development of drug candidates throughout her career. She co-founded three start-up companies and successfully brought three novel cancer drug candidates and two other drug candidates in pain and infectious diseases from bench into human clinical trials. Following the acquisition of the first company she co-founded, ProlX Pharmaceuticals, she became President and CEO of Ensysce Biosciences Inc. and took the company public in 2021. Now Dr. Kirkpatrick is guiding the clinical development of Ensysce’s highly novel pain products, which use compelling chemical approaches to reduce abuse and overdose potential. Dr. Kirkpatrick received her PhD in Medicinal Chemistry from the University of Saskatchewan and completed a post-doctoral fellowship in Pharmacology at Yale University School of Medicine before returning to Canada where she spent 16 years in academia. She has published extensively in the area of targeted cancer drug discovery and development and holds numerous patents for novel drug candidates. Company Bio: Ensysce Biosciences is developing first-in-class and uniquely innovative solutions in oral drug delivery. Our proprietary TAAP™ and MPAR® technologies improve the care and safety of patients by preventing the possibility of both abuse and overdose of prescription drugs. Our mission is to revolutionize the safety and oral delivery of medicines for areas of high unmet need. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This Biotech CEO Is Using Neuroplastogenic Small-Molecule Therapeutics To Create Next Generation Mental Health. Dr Joseph Tucker – CEO Enveric $ENVB Guest: Dr. Joseph Tucker – CEO – Enveric Biosciences Website: https://www.enveric.com/ Company Bio: Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida. Dr. Tucker Bio: Dr. Tucker is a seasoned executive who has built several publicly traded biotechnology companies. Dr. Tucker was a founder and Chief Executive Officer of Stem Cell Therapeutics, which he took public on the TSX (TSX: SSS). Trillium Therapeutics (NASDAQ: TRIL, TSX: TRIL) acquired Stem Cell Therapeutics in 2013. Dr. Tucker has also held the position of Co-Founder and Chief Executive Officer of Epimeron Inc., a University of Calgary start-up acquired in the creation of Willow Biosciences Inc. (TSX: WLLW). At Willow, Dr. Tucker served as Executive Chairman and Chief Operating Officer. Prior to founding companies, Dr. Tucker was a healthcare analyst with two investment banks and has also worked in technology commercialization for a university technology transfer office. Dr. Tucker received his Ph.D. in Biochemistry and Molecular Biology from the University of Calgary. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

This CEO Is Using Alpaca DNA To Fight Inflammation & A Lot More! CEO Scinai… Nasdaq $SCNI Guest: Mr. Amir Reichman Title & Company: CEO Scinai Immunotherapeutics Ticker: SCNI Website : https://www.scinai.com/ Bio: Mr. Amir Reichman was appointed as Scinai’s CEO in 2021. Born and educated in Israel, Mr. Reichman most recently served as Head of Global Vaccines Engineering Core Technologies and Asset Management at GSK Vaccines headquarters in Belgium. Prior to his role in global vaccines engineering, he served as Senior Director Global GSK Vaccines Supply Chain. Mr. Reichman joined GSK in 2015 after its acquisition of Novartis Vaccines. At Novartis Vaccines, he held various leadership roles of increasing responsibility in its Global Vaccines Supply Chain Management organization located in Holly Springs, NC, USA. In 2003, Mr. Reichman’s academic work at Ben-Gurion University of the Negev contributed to the founding of NeuroDerm Ltd., an Israeli company focused on transdermal drug delivery systems that was acquired by Mitsubishi Tanabe Pharma in 2017 for $1.1B. He was NeuroDerm’s first employee and served as the company’s Chief Engineer and Senior Scientist until his departure in 2009. Mr. Reichman earned an M.Sc. in Biotechnology Engineering from the Ben-Gurion University of the Negev in Israel, and an MBA in Finance and Health Care Management from the Wharton School of the University of Pennsylvania, USA.” --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

How This CEO Is Revolutionizing The Smart Eyewear Market… Innovative Eyewear CEO & Founder - $LUCY Guest: Harrison Gross Founder & CEO Innovative Eyewear $LUCY Ticker: LUCY Website: https://lucyd.co/ Bio: CEO & COFOUNDER HARRISON GROSS Harrison Gross is one of the founders of Innovative Eyewear and has served as our Chief Executive Officer and as a director since August 2019, where he guides the company’s product and brand development. Prior to his employment at Innovative Eyewear, from August 2017 to August 2019, Mr. Gross served in various positions, including chief executive officer and media & UX lead, of Lucyd Ltd., our largest stockholder and the licensor of our technology which is also a smart eyewear development company where he developed the company’s brand identity and oversaw general operations and product development. Additionally, from November 2015 to August 2021, Mr. Gross served as the Digital Media Manager of Tekcapital PLC (“Tekcapital”) (LON: TEK), a university intellectual property investment firm that is the parent company of Tekcapital Europe Limited, and Lucyd Ltd, the holding company for Tekcapital’s shares in Innovative Eyewear, where he created, developed and marketed for the company’s licensed properties. Prior to that, from October 2013 to September 2014, Mr. Gross worked as a credit analyst for a Verizon, Inc. contractor, where he managed credit systems and provided support to Verizon agents. Mr. Gross is a graduate of Columbia University with a BA in Writing and received a BA in Jewish Studies from the Jewish Theological Seminary. Mr. Gross is well qualified to serve as a director due to his substantial knowledge of our products, being a named inventor of most of the Company’s patents and his experience in marketing, product and app development. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Never Stop Learning With IoT Pioneer David  Ly Founder & CEO Iveda – $IVDA Ticker: $IVDA (Nasdaq) Website: https://iveda.com/ Bio: David Ly is the visionary leader and founder of Iveda. David has served as CEO and Chairman of the Board of Directors since the Company’s inception. He also served as President until February 2014. David has over 20 years of experience in wireless data, cellular, IT, and cloud video surveillance. He was only 27 years old when he founded the Company in 2003 and has become a dynamic leader, building a pioneering cloud video hosting and real-time surveillance infrastructure. David’s major accomplishments include raising over $12 million through angel investors, building an enterprise-class cloud video and IoT platforms, taking the company public, and acquiring a security technology company in Taiwan, positioning Iveda for global growth. David is also responsible for securing the Company’s U.S. and international accounts and forging strategic partnerships with large organizations. Prior to founding the company, David had a successful career in sales and applications engineering. He held positions with several major corporations, including Applications Engineer at Metricom, Inc., Corporate Sales at Nextel Communications, Market Manager at Door To Door Storage, and B2B Sales Manager at T-Mobile USA. While at T-Mobile, David earned the President’s Club Top Salesman Award. David’s experience in sales and marketing and his clear vision of video surveillance through cloud computing have been invaluable to the Company’s success. He served in numerous technology, community, and law enforcement Boards of Directors and Advisory Boards. David received his B.S. Degree in Civil Engineering with a Minor in International Business from San Francisco State University in California. --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support